Studies whether sleep apnea links to a type of glaucoma
Observes people with sleep apnea and normal tension glaucoma through eye and sleep tests.
Key facts
- Who runs it
- Northwell Health
- Where
- New York, United StatesSee the site
- Trial code
- Registry title
- Obstructive Sleep Apnea as a Risk Factor for Normal Tension Glaucoma and a Crucial Step in Preventing Blindness
- Status
- Not yet recruiting
- People taking part
- 100 people, planned
- Started
- 2 Sept 2025
- Expected to end
- 1 Sept 2028
- Type of study
- Observational, 3 groups
- Treatments tested
- Clinical observation, diagnostic testing
- Record updated
- 10 June 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who were newly diagnosed with obstructive sleep apnea and will start CPAP treatment. It studies the link between sleep apnea and normal tension glaucoma.
- Age
- At least 21 years old.
- Sex
- All sexes can join.
- Disease stage
- Newly diagnosed obstructive sleep apnea (OSA).
- Earlier treatment
- People must be about to start CPAP treatment for sleep apnea. People with a history of severe eye trauma, eye inflammation or eye surgery cannot join, except uncomplicated cataract surgery with a lens implant.
Main reasons for not taking part
- Narrow angle glaucoma
- High glasses prescription: over ±6.0 diopters, or cylinder over -3.0 D
- History of severe eye trauma, eye inflammation or eye surgery (except uncomplicated cataract surgery with lens implant)
- Diabetic retinopathy or other retinal changes that prevent a reliable check of the optic disc
- Allergy to any component of altafluor benox
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Newly diagnosed subjects with OSA that will undergo CPAP treatment
- At least 21 years of age
- Best corrected vision of 20/40 or better, spherical Rx < ± 6.0 Diopter, and cylinder <-3.0D
- Ability to follow instructions, and intent to complete all study visits
Who cannot take part
- History of any of the following: severe eye trauma, ocular inflammation, previous intraocular surgery except for uncomplicated cataract extraction with posterior chamber intraocular lens implantation
- Any medical or ocular condition which is not appropriate for participation in the trial (Diabetic retinopathy, and other retinal changes preventing reliable optic disc evaluation) Hypersensitivity to any component of altafluor benox
- High Rx >± 6.0D and cylinder > -3.0D
- Narrow angle glaucoma
Where in United States
- Manhattan Eye, Ear & Throat HospitalNew York, United StatesContact: Andrew Tirsi, MDNot yet recruiting
About the trial
What the trial wants to find out
The purpose of this research study is to learn more about the relationship between Obstructive Sleep Apnea (OSA) and Normal Tension Glaucoma (NTG). OSA is a nighttime disorder of the upper airway that causes an intermittent lack of oxygen while sleeping. NTG is a type of glaucoma that occurs despite the normal intraocular pressure levels, making its detection more difficult. Left untreated, irreversible optic nerve damage and extensive vision loss can result. Previous research has shown some evidence between OSA and the development of NTG. The investigators are researching whether undergoing treatment for OSA would help to improve the vascular health to the retina, and in effect, improve the early signs of visual dysfunction seen with diagnostic testing.
The 3 groups in the trial
- Newly-diagnosed mild OSA - initiating CPAP treatment
Subjects with newly-diagnosed mild obstructive sleep apnea being treated with CPAP undergoing clinical observation/diagnostic evaluation for detection and tracking of NTG.
Treatment: Clinical observation, diagnostic testing
- Newly-diagnosed moderate OSA - initiating CPAP treatment
Subjects with newly-diagnosed moderate obstructive sleep apnea being treated with CPAP undergoing clinical observation/diagnostic evaluation for detection and tracking of NTG.
Treatment: Clinical observation, diagnostic testing
- Newly-diagnosed severe OSA - initiating CPAP treatment
Subjects with newly-diagnosed severe obstructive sleep apnea being treated with CPAP undergoing clinical observation/diagnostic evaluation for detection and tracking of NTG.
Treatment: Clinical observation, diagnostic testing
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Obstructive Sleep Apnea as a Risk Factor for Normal Tension Glaucoma and a Crucial Step in Preventing Blindness
- Plain-language title
- Studies whether sleep apnea links to a type of glaucomaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 10 June 2025